94 related articles for article (PubMed ID: 18024636)
1. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice.
Haimovich J; Kukulansky T; Weissman B; Hollander N
Cancer Immunol Immunother; 1999 Feb; 47(6):330-6. PubMed ID: 10203063
[TBL] [Abstract][Full Text] [Related]
2. Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees.
Varghese B; Widman A; Do J; Taidi B; Czerwinski DK; Timmerman J; Levy S; Levy R
Blood; 2009 Nov; 114(20):4477-85. PubMed ID: 19762487
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of B lymphoma by anti-idiotype antibodies: characterization of variant tumour cells appearing a long time after the initial tumour inoculation.
Taya M; Haimovich J
Cancer Immunol Immunother; 1991; 34(1):43-8. PubMed ID: 1760810
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for B-cell lymphoma: current status and prospective advances.
Hollander N
Front Immunol; 2012; 3():3. PubMed ID: 22566889
[TBL] [Abstract][Full Text] [Related]
5. First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
Kwak L; Szymura S; Wang L; Zhang T; Cha SC; Dong Z; Anderson A; Oh E; Lee V; Wang Z; Parshottham S; Rao S; Olsem J; Crumpton B; Lee H; Manasanch E; Neelapu S; Thomas S
Res Sq; 2023 Sep; ():. PubMed ID: 37790486
[TBL] [Abstract][Full Text] [Related]
6. Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma.
Tusé D; Ku N; Bendandi M; Becerra C; Collins R; Langford N; Sancho SI; López-Díaz de Cerio A; Pastor F; Kandzia R; Thieme F; Jarczowski F; Krause D; Ma JK; Pandya S; Klimyuk V; Gleba Y; Butler-Ransohoff JE
Biomed Res Int; 2015; 2015():648143. PubMed ID: 26425548
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.
Alvaro T; de la Cruz-Merino L; Henao-Carrasco F; Villar Rodríguez JL; Vicente Baz D; Codes Manuel de Villena M; Provencio M
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20814546
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccines: developing new strategies against cancer.
Fioretti D; Iurescia S; Fazio VM; Rinaldi M
J Biomed Biotechnol; 2010; 2010():174378. PubMed ID: 20368780
[TBL] [Abstract][Full Text] [Related]
9. A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells.
Grille S; Brugnini A; Nese M; Corley E; Falkenberg FW; Lens D; Chabalgoity JA
Cancer Immunol Immunother; 2010 Apr; 59(4):519-27. PubMed ID: 19768458
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
[TBL] [Abstract][Full Text] [Related]
11. Translational development of vaccination strategies in follicular NHL.
Sakamaki I; Qin H; Kwak LW
Best Pract Res Clin Haematol; 2011 Jun; 24(2):295-304. PubMed ID: 21658625
[TBL] [Abstract][Full Text] [Related]
12. Vaccine therapy for B-cell lymphomas: next-generation strategies.
Neelapu SS; Kwak LW
Hematology Am Soc Hematol Educ Program; 2007; ():243-9. PubMed ID: 18024636
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
Bertinetti C; Zirlik K; Heining-Mikesch K; Ihorst G; Dierbach H; Waller CF; Veelken H
Cancer Res; 2006 Apr; 66(8):4496-502. PubMed ID: 16618777
[TBL] [Abstract][Full Text] [Related]
15. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
